COVID-19 2nd Phase - Impact on Physicians’ Practice - Syndicated Study
hemato-oncology, COVID-19, Syndicated Studies, Oncology
How does COVID-19 affect the HCPS relationships with patients and with the pharmaceutical...
Posts about
hemato-oncology
DLBCL Patient Insights in the US and EU5
When working on a new or existing brand within the DLBCL market it's important to have up to...
DLBCL Treatment Performance in EU5 and US
hemato-oncology, Tracking Studies, DLBCL market
The DLBCL market is undergoing a period of change, and the relative performance of the various...
DLBCL Market Overview
hemato-oncology, Tracking Studies, DLBCL market
Following the release of our latest ebook, this is the first blog post in this series focusing...
New AplusA eBook Covers the DLBCL Market
Introducing the latest eBook in AplusA's Hemato-Oncology series
Patient Insights from AplusA’s Multiple Myeloma Tracker
A thoughtfully developed tracker can provide deep insights on any therapeutic area. Using the...
Multiple Myeloma Market Dynamics Revealed by AplusA Tracker
A thoughtfully developed tracker can provide deep insights on any therapeutic area. Using the...
Brand Performance Insights from AplusA's Multiple Myeloma Tracker
A thoughtfully developed tracker can provide deep insights on any therapeutic area. Using the...
Key Insights from a Multiple Myeloma Tracker
A thoughtfully developed tracker can provide deep insights on any therapeutic area. Using the...
Who Are The Key Hemato-Oncology Market Stakeholders?
Healthcare Industry, hemato-oncology
As a marketing professional in the healthcare industry, you need to accurately identify the...